CATALYST PHARMACEUTICALS PARTNERS, INC.

Company

CATALYST PHARMACEUTICALS, INC.

Filed

April 29, 2008

Period of Report

June 18, 2008

Accession Number

0000950144-08-003341

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →